We’re still figuring out the side effects of GLP-1 weight-loss drugs

This week my colleague Antonio Regalado had an interesting update on GLP-1 weight-loss drugs.

The Core Event

According to research presented at an aging meeting in Boston, these drugs seem to affect at least some measures of biological age .

Key Facts

Overweight and diabetic people who take GLP-1s have a biological age around two to three years younger than similar individuals who take a placebo, according to findings from Eli Lilly and Novo Nordisk, two pharmaceutical companies that make the drugs.

Context & Significance

According to research presented at an aging meeting in Boston, these drugs seem to affect at least some measures of biological age .

Outlook

Stay updated with continuous reporting from MIT Tech Review.